Clinical Trials - January 7, 2015
Ebola Vaccine Trial Starts
An initiation of a Phase 1, first-in-human clinical trial of the preventative Ebola vaccine regimen consisting of MVA-BN® Filo and the AdVac® technology from Crucell Holland B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, took place recently, said Bavarian Nordic A/S. The first volunteers have received their initial vaccine dose and recruitment […]
Acquisition - January 7, 2015
Novo Renews Racing Pact
Novo Nordisk and the Chip Ganassi Racing Teams (CGRT) have inked a multi-year extension of their partnership, renewing Novo Nordisk as the primary sponsor of the No. 83 Novo Nordisk Chip Ganassi Racing entry, driven by Charlie Kimball in the Verizon IndyCar Series. Kimball, 29, from Camarillo, California, is the first and only licensed driver with diabetes […]
Uncategorized - January 6, 2015
Study Examines How Cells Store, Burn Fat
Researchers in the department of biochemistry and molecular biology at the University of Southern Denmark have discovered how cells responsible for storing fat can be converted into cells that burn fat. Scientists identified a protein that activates specific genes to reprogram the fat cells to burn fat instead of storing it. The findings are an important step in […]
Collaboration - January 6, 2015
Potential Drugs Get 2nd Chance
To give some potential drugs a second chance, AstraZeneca PLC, GlaxoSmithKline and five other companies have created a library of 68 compounds that did not make it to market, in the hope is that one of the other partners will be able to complete development and get the product on the market. AstraZeneca reached an agreement with the Medical […]
In a new job - January 6, 2015
Novo’s Soerensen to Step Down
Novo Nordisk’s board likely will begin its search soon for the successor to Chief Executive Officer Lars Rebien Soerensen, who recently announced he will not serve out the rest of his contract to 2019 and could leave his post as early as next year. Among the names mentioned is the company’s President Kaare Schultz, who was […]
Uncategorized - January 5, 2015
Finland Tops for Biobank Research
Finland is one of the best countries in the world for conducting biobank research, according to Olli Carpén, Professor of Pathology at the University of Turku. It offers the opportunity to collect population-based, comprehensive samples for many disease groups, notes Carpén. “Finnish people have a very positive attitude towards medical research. Consenting to give a […]